Medicare Enrolled

Dr. Josna Haritha, MD

Rheumatology · Elk Grove Village, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
800 BIESTERFIELD RD STE 4003, Elk Grove Village, IL 60007
8473640800
In practice since 2013 (13 years)
NPI: 1922445097 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Haritha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Haritha? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Haritha

Dr. Josna Haritha is a rheumatology specialist in Elk Grove Village, IL, with 13 years of NPI registration. Based on federal Medicare data, Dr. Haritha performed 3,200 Medicare services across 394 unique beneficiaries.

Between the years covered by Open Payments, Dr. Haritha received a total of $8,951 from 38 pharmaceutical and/or device companies across 432 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Haritha is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 38% volume in IL $8,951 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,200
Medicare services
Top 38% in IL for rheumatology
394
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~246 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 2,400 $18 $29
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
247 $99 $393
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
188 $62 $223
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
134 $138 $550
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
83 $111 $404
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
82 $1 $75
New patient office visit, complex (60-74 min) 66 $170 $589
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.2% high complexity
80.9% medium
14.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$8,951
Total received (2018-2024)
Avg $1,279/year across 7 years
Top 23% in IL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
432
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,694 (97.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$257 (2.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,126
2023
$1,321
2022
$1,368
2021
$1,013
2020
$864
2019
$724
2018
$1,535

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$496
Amgen Inc.
$412
Novartis Pharmaceuticals Corporation
$203
UCB, Inc.
$131
Boehringer Ingelheim Pharmaceuticals, Inc.
$125
GlaxoSmithKline, LLC.
$99
Sandoz Inc.
$86
PFIZER INC.
$85
Alexion Pharmaceuticals, Inc.
$80
Lilly USA, LLC
$74
AstraZeneca Pharmaceuticals LP
$69
ANI Pharmaceuticals, Inc.
$59
Janssen Biotech, Inc.
$46
Genentech USA, Inc.
$30
Aurinia Pharma U.S., Inc.
$28
Kiniksa Pharmaceuticals International, plc
$27
Janssen Pharmaceuticals, Inc
$26
IDORSIA PHARMACEUTICALS US INC
$20
Organon Llc
$15
SHORLA ONCOLOGY INC.
$14
Top 3 companies account for 52.3% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,395
ABBVIE INC.
$1,022
AbbVie, Inc.
$844
AbbVie Inc.
$540
PFIZER INC.
$485
Lilly USA, LLC
$452
Novartis Pharmaceuticals Corporation
$418
E.R. Squibb & Sons, L.L.C.
$411
GENZYME CORPORATION
$390
Janssen Biotech, Inc.
$354
Boehringer Ingelheim Pharmaceuticals, Inc.
$346
Horizon Therapeutics plc
$324
UCB, Inc.
$300
GlaxoSmithKline, LLC.
$225
Horizon Pharma plc
$190
AstraZeneca Pharmaceuticals LP
$150
Aurinia Pharma U.S., Inc.
$113
Sandoz Inc.
$111
Genentech USA, Inc.
$91
Actelion Pharmaceuticals US, Inc.
$90
Sobi, Inc
$89
ANI Pharmaceuticals, Inc.
$87
Alexion Pharmaceuticals, Inc.
$80
Radius Health, Inc.
$73
Hikma Pharmaceuticals USA
$72
Mallinckrodt Hospital Products Inc.
$59
IDORSIA PHARMACEUTICALS US INC
$37
Kiniksa Pharmaceuticals International, plc
$27
Janssen Pharmaceuticals, Inc
$26
Avanos Medical
$24
Mallinckrodt Enterprises LLC
$19
FIDIA PHARMA USA INC.
$18
Biocon Biologics Inc
$17
Melinta Therapeutics, Inc.
$16
Shire North American Group Inc
$16
Organon Llc
$15
SHORLA ONCOLOGY INC.
$14
Electromed, Inc.
$12
Top 3 companies account for 36.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CUVITRU · CYLTEZO · Cimzia · EVENITY · EVUSHELD · Enbrel · FORTEO · GENVISC 850 SODIUM HYALURONATE · HADLIMA · HUMIRA · HYRIMOZ · Hulio · Humira · Hymovis · ILARIS · JYLAMVO · KEVZARA · KRYSTEXXA · Kineret · LUPKYNIS · Mitigare · OFEV · OPSUMIT · ORENCIA · Otezla · PURIFIED CORTROPHIN GEL · QUVIVIQ · RAYOS · REMICADE · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rinvoq · Rituxan · SIMPONI ARIA · SKYRIZI · SMARTVEST · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · UPTRAVI · Vabomere · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Elk Grove Village?
Compare rheumatologists in the Elk Grove Village area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
164
Per 100K population
3.2
County median income
$81,797
Nearest hospital
ALEXIAN BROTHERS MEDICAL CENTER 1
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Haritha is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Haritha experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Haritha performed 2,400 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Haritha receive payments from pharmaceutical companies?
Yes. Dr. Haritha received a total of $8,951 from 38 companies across 432 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Haritha's costs compare to other rheumatologists in Elk Grove Village?
Dr. Haritha's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Haritha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →